Scotland’s pharmaceutical regulatory authority the Scottish Medicines Consortium (SMC) has recommended Jazz Pharmaceutical spin-off EUSA Pharma’s fotivda (tivozanib) for the...
Read More...
The post EUSA Pharma’s tivozanib drug approved for kidney cancer in Scotland appeared first on Pharmaceutical Technology.
Original Article: EUSA Pharma’s tivozanib drug approved for kidney cancer in Scotland